Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.

doi:10.1111/bjh.14640

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.

British journal of haematology - 1 Jul 2017

Sinakos Emmanouil, Kountouras Dimitrios, Koskinas John, Zachou Kalliopi, Karatapanis Stylianos, Triantos Christos, Vassiliadis Themistoklis, Goulis Ioannis, Kourakli Alexandra, Vlachaki Efthymia, Toli Barbara, Tampaki Maria, Arvaniti Pinelopi, Tsiaoussis Georgios, Bellou Aristea, Kattamis Antonis, Maragkos Konstantinos, Petropoulou Foteini, Dalekos George N, Akriviadis Evangelos, Papatheodoridis George V

Abstract excerpt

Interferon-based regimens for chronic hepatitis C (CHC) were often deferred in patients with β-thalasaemia major (β-TM) due to poor efficacy and tolerance. Current guidelines recommend direct-acting antivirals (DAAs) for these patients. The aim of this study was to assess the safety and efficacy of DAAs in patients with β-TM and advanced liver disease due to CHC. Patients were recruited from eight liver units in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Thalassemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carbamates

Share to Imidazoles

Share to Pyrrolidines

Source

Open in PubMed

Identifiers

PMID: 28439915
DOI: 10.1111/bjh.14640

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.PMID 28439915Read ↗

Effectiveness And Safety Of Direct Acting Antiviral Agents In Thalassaemic Patients With Chronic Hepatitis C.Semantic proximity Read ↗

Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis.Semantic proximity Read ↗

Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus.Semantic proximity Read ↗

Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older.Semantic proximity Read ↗

[Interferon treatment of chronic hepatitis C: basic immunobiology and immunopathology of the liver].Semantic proximity Read ↗

Sofosbuvir/Ledipasvir for Treatment of Chronic Hepatitis C Infection in Adult Patients with β- Thalassemia Major: A Real-Life Study.Semantic proximity Read ↗

Direct-Acting Antiviral Use for Genotype 1b Hepatitis C Patients with Associated Hematological Disorders from Romania.Semantic proximity Read ↗

Efficacy and Safety of Direct Acting Antiviral Therapy for Chronic Hepatitis C in Thalassemic Children.Semantic proximity Read ↗

[Efficacy and tolerance of direct-acting antiviral drugs for the treatment of hepatitis C in Joseph Raseta Befelatanana Teaching Hospital in Antananarivo, Madagascar].Semantic proximity Read ↗

100% sustained virological response and fibrosis improvement in real-life use of direct acting antivirals in genotype-1b recurrent hepatitis C following liver transplantation.Semantic proximity Read ↗

Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?Semantic proximity Read ↗

Efficacy of Interferon A-2b monotherapy in Β-thalassemics with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.